Agomab Therapeutics AGMB
NASDAQ AGMB
$11.37 -0.33 (-2.82%)
As of: Sep 22, 2026 · 10:46 AM EDT

Agomab Therapeutics NV (AGMB) Intangibles (2024 - 2026)

Agomab Therapeutics (AGMB) posted Intangibles of $23.4 million for Q2 2026, little changed on a QoQ basis from $23.4 million in Q4 2025.

Analysis

Agomab Therapeutics NV (AGMB) Intangibles (2024 - 2026) Analysis & Trends

Agomab Therapeutics has reported Intangibles for 3 years, with the latest figure at $23.4 million in Q2 2026.

  • On a quarterly basis, Intangibles changed N/A year-over-year to $23.4 million in Q2 2026; TTM through Jun 2026 was $23.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $23.4 million, up 7.55% from the prior year.
  • Intangibles was $23.4 million for Q2 2026 at Agomab Therapeutics, roughly flat from $23.4 million in the prior quarter.
  • The five-year high for Intangibles was $23.4 million in Q4 2025, with the low at $21.5 million in Q4 2024.
  • Average Intangibles over 3 years is $22.8 million, with a median of $23.4 million recorded in 2026.
  • The largest YoY upside for Intangibles was 8.93% in 2025 against a maximum downside of 8.93% in 2025.
  • Over 3 years, Intangibles stood at $21.5 million in 2024, then advanced by 8.93% to $23.4 million in 2025, then declined by 0.14% to $23.4 million in 2026.
  • The last three Intangibles figures came in at $23.4 million (Q2 2026), $23.4 million (Q4 2025), and $21.5 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.38 Mn
Dec 31, 2025 23.41 Mn
Dec 31, 2024 21.49 Mn
API Access

Agomab Therapeutics NV Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=AGMB&period=max&api_key=YOUR_API_KEY